Vectura revenue jumps 59 pct, beats estimates

May 20, 2015 6:33 AM

17 0

May 20 Respiratory drugs specialist Vectura Group Plc reported a bigger-than-expected jump in full-year revenue as it raked in higher royalty payments and licensing revenue.

The company, which develops and markets drugs for illnesses such as asthma and chronic obstructive pulmonary disease, said revenue rose to 58 million pounds ($89.8 million) in the year ended March 31 from 36.5 million pounds a year earlier.

Also read: Maine airport moves to 100 percent recycled de-icing fluid

Read more

To category page